• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FERRING / BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FERRING / BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Lot Number N15006A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arthritis (1723); Death (1802)
Event Date 06/22/2018
Event Type  Death  
Event Description
Pt was reported as deceased as of (b)(6) 2018.Bilateral primary osteoarthritis of knee.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUFLEXXA
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
FERRING / BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.
MDR Report Key9238861
MDR Text Key163908300
Report NumberMW5090646
Device Sequence Number1
Product Code MOZ
UDI-Device Identifier55566410001
UDI-Public55566-4100-01
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 10/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date06/03/2019
Device Lot NumberN15006A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/24/2019
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization;
Patient Age92 YR
-
-